INS and metabolic syndrome: The intervention with IPA reduced the body weight and peripheral fat content; improved insulin resistance, liver lipid deposition, and peripheral blood lipid content; and maintained intestinal homeostasis, thereby improving metabolic syndrome (Table 2).